GGrantIndex
Sort

261,768 grants matching gene therapy

Targeting Lung Cancer Vulnerabilities

$2,188,505
John D Minna · Ut Southwestern Medical Center · P50 · FY2024 · CA

SOUTH CAROLINA COBRE IN OXIDANTS, REDOX BALANCE AND STRESS SIGNALING

$2,188,354
Kenneth D. Tew · Medical University Of South Carolina · P20 · FY2015 · GM

DNA virus as vectors for cardiovascular diseases

$2,187,963
James M Wilson · University Of Pennsylvania · P01 · FY2011 · HL

Women's Interagency HIV Study (WIHS-V)

$2,187,948
Kathryn M Anastos · Albert Einstein College Of Medicine · U01 · FY2015 · AI

Structural Basis of Biological Membrane Protein Functions and Drug Resistance

$2,187,700
Di S Xia · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Cycles of Social Contingency in Autism: Pivotal Transitions that Shape Infant Brain-Behavior Development in Human & Model Systems

$2,187,612
Ami Klin · Emory University · P50 · FY2020 · MH

Regulation of mitochondrial DNA homeostasis and neuroinflammation by Fascin in Alzheimer’s Disease

$2,187,498
Yongchao Charles Ma · Lurie Children'S Hospital Of Chicago · RF1 · FY2022 · AG

Targeting Pten - An Upstream, Downstream and Offstream Approach

$2,187,046
Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2012 · CA

Washington University SPORE in Pancreatic Cancer

$2,186,724
William G Hawkins · Washington University · P50 · FY2016 · CA

SPORE in Skin Cancer

$2,186,705
Meenhard Herlyn · Wistar Institute · P50 · FY2023 · CA

The Memorial Sloan Kettering Cancer Center SPORE in Leukemia

$2,186,396
Omar Abdel-Wahab · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA

Harvard Genome Characterization Center

$2,186,017
Raju S Kucherlapati · Brigham And Women'S Hospital · U24 · FY2010 · CA

DCTD Screening Technologies

$2,185,989
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2012 · CA

Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer

$2,185,934
Dawn E Quelle · University Of Iowa · P50 · FY2025 · CA

Novel Therapeutic Strategies in Human Myeloid Leukemias

$2,185,917
Dana-Farber Cancer Institute · P01 · FY2005 · CA

BIOLOGY OF OVARIAN CANCER

$2,185,892
University Of California San Francisco · P01 · FY2004 · CA

Point-of care Microfluidics for Early Detection of Cancer

$2,185,654
Mehmet Toner · Massachusetts General Hospital · U01 · FY2014 · EB

Immunopathogenesis of Fungal Infections

$2,185,404
Michail Lionakis · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

SPORE In Prostate Cancer

$2,185,002
William George Nelson · Johns Hopkins University · P50 · FY2011 · CA

Mayo Clinic SPORE in Pancreatic Cancer

$2,185,002
Gloria M. Petersen · Mayo Clinic Rochester · P50 · FY2015 · CA

SPORE in Prostate Cancer

$2,185,001
Arul M Chinnaiyan · University Of Michigan At Ann Arbor · P50 · FY2015 · CA

Mayo Clinic Breast Cancer SPORE

$2,185,001
Matthew Philip Goetz · Mayo Clinic Rochester · P50 · FY2015 · CA

Experimental Therapeutics of Leukemia

$2,185,000
John C Byrd · Ohio State University · P50 · FY2011 · CA

SARC Sarcoma SPORE

$2,185,000
Laurence H Baker · Sarc · U54 · FY2015 · CA

Mayo Clinic Multiple Myeloma SPORE

$2,185,000
Peter Leif Bergsagel · Mayo Clinic Arizona · P50 · FY2015 · CA